Table 1 Patients characteristics and association with baseline pTKa
Characteristics | N (%) | Median TKa Du/L [IQR] | p value |
|---|---|---|---|
Age | |||
< 65 years | 53 (51) | 455 [117–1325] | 0.2 |
≥ 65 years | 50 (49) | 233 [70–705] | |
Performance status | |||
0–1 | 95 (92) | 320 [86–865] | 0.9 |
≥ 2 | 8 (8) | 247 [150–789] | |
Grade | |||
1 | 15 (15) | 482 [99–771] | 0.8 |
2 | 61 (61) | 292 [117–917] | |
3 | 24 (24) | 286 [68–710] | |
Missing value | 3 | ||
Progesterone receptor | |||
Negative | 29 (28) | 436 [117–1361] | 0.1 |
Positive | 74 (72) | 237 [73–546] | |
Synchronous metastasis | |||
No | 71 (69) | 195 [85–640] | 0.1 |
Yes | 32 (31) | 476 [111–1292] | |
Visceral metastasis | |||
No | 35 (34) | 249 [116–483] | 0.6 |
Yes | 68 (66) | 327 [87–1033] | |
Primary endocrine resistance | |||
No | 86 (83) | 237 [73–588] | 0.04 |
Yes | 17 (17) | 758 [233–1641] | |
Previous chemotherapy | |||
No | 48 (47) | 214 [61–781] | 0.4 |
1 or 2 lines | 34 (33) | 330 [120–704] | |
≥ 3 lines | 21 (20) | 466 [157–1281] | |